Neurosurgery
-
Current standard treatment of microprolactinomas is dopamine agonist therapy. As this drug treatment is lifelong in up to 80% of cases, many patients consult pituitary surgeons regarding a surgical alternative. ⋯ According to our results, remission rate is significantly higher in microprolactinomas enclosed by the pituitary gland. However, the decision for surgery should take into account surgeons experience and possibility of complications.
-
Observational Study
Quality of British and American Nationwide Quality of Care and Patient Safety Benchmarking Programs: Case Neurosurgery.
Multiple nationwide outcome registries are utilized for quality benchmarking between institutions and individual surgeons. ⋯ The implemented benchmarking programs in the United Kingdom and United States fail to identify a considerable number of complications in a high-volume center. Health care policy makers should be cautious as outcome comparisons between most centers and individual surgeons are questionable if based on the programs.